99 related articles for article (PubMed ID: 2206815)
1. Pharmacokinetic study of controlled-release choline theophyllinate in elderly patients.
Mondal BK; Beck PR; Gregory J; le Cotonnec JY; Clarke I
Br J Clin Pract; 1990 Jun; 44(6):223-5. PubMed ID: 2206815
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
3. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
[TBL] [Abstract][Full Text] [Related]
4. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
5. The influence of orally administered cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction.
Hsu K; Garton A; Sproule BJ; Tam YK; Legatt D; Herbert FA
Am Rev Respir Dis; 1984 Nov; 130(5):740-3. PubMed ID: 6497156
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic pharmacokinetics of asymmetrical doses of slow release choline theophyllinate in asthma.
Hibberd SG; Alveyn C; Coombes EJ; Holgate ST
Br J Clin Pharmacol; 1986 Sep; 22(3):337-41. PubMed ID: 3768245
[TBL] [Abstract][Full Text] [Related]
7. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
González MA; Straughan AB
Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of bronchodilation in chronic reversible airways obstruction. Comparison between choline theophyllinate and salbutamol.
Tanser AR
Practitioner; 1982 Mar; 226(1365):569-71. PubMed ID: 7045848
[No Abstract] [Full Text] [Related]
9. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations.
Cova D; Cuglituri G; Rossini L; Bonfardeci G
Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetics of theophylline. Repeated single evening administration of Pulmo-Timelets slow-release capsules in comparison with theophylline slow-release tablets].
Heusinger JH; Breuel HP; Behrendt WA; Wolfstädter HD
Fortschr Med; 1989 Nov; 107(32):692-6. PubMed ID: 2689314
[TBL] [Abstract][Full Text] [Related]
11. [Multicenter study with a large number of patients for the validation of pharmacokinetic and clinical findings from controlled studies with small patient cohorts].
Götz JK; Sauter R
Pneumologie; 1991 Nov; 45 Suppl 4():867-74. PubMed ID: 1812482
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
13. A comparative trial of choline theophyllinate (Choledyl) and controlled release aminophylline (Phyllocontin).
Maneksha S
Br J Clin Pract; 1978 Feb; 32(2):52-5. PubMed ID: 666955
[No Abstract] [Full Text] [Related]
14. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
Langston VC; Koritz GD; Davis LE; Neff-Davis C
Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic properties of a new sustained-release theophylline preparation.
Dahlqvist R; Billing B
Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic characteristics of a new liquid sustained-release formulation of theophylline designed for the elderly and children: microcaps as sachet.
Fuchs WS; Weiss G; Von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
Int J Clin Pharmacol Ther; 1996 Dec; 34(12):558-63. PubMed ID: 8996853
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of plasma levels of 2 delayed-action theophyllines: Theostat 200 and Theodur 200, after a single evening dose].
Philip-Joet F; Bruguerolle B; Lagier F; Arnaud A
Rev Pneumol Clin; 1986; 42(6):279-83. PubMed ID: 3563255
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
Valet SB; Schwartz RH; Brooks JG
Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
[TBL] [Abstract][Full Text] [Related]
20. A single-blind crossover study of two different slow release theophylline preparations.
Tatsis G; Danos J; Gaga M; Pantelakis D; Veslemes M; Jordanoglou J
J Int Med Res; 1988; 16(6):452-8. PubMed ID: 3069520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
